U-Blot® Research Grade afivastobartCat. No. WA1036Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade afivastobartCat. No. WA1036U-Blot® Research Grade afimkibartCat. No. WA1035Request quote
Size: 50ug/100ug
U-Blot® Research Grade AfelimomabCat. No. WA1034Request quote
Size: 50ug/100ug
U-Blot® Research Grade AfasevikumabCat. No. WA1033Request quote
Size: 50ug/100ug
U-Blot® Research Grade AducanumabCat. No. WA1032Request quote
Size: 50ug/100ug
U-Blot® Research Grade AdintrevimabCat. No. WA1031Request quote
Size: 50ug/100ug
U-Blot® Research Grade adimanebartCat. No. WA1030Request quote
Size: 50ug/100ug
U-Blot® Research Grade adezkibartCat. No. WA1029Request quote
Size: 50ug/100ug
U-Blot® Research Grade AdecatumumabCat. No. WA1028Request quote
Size: 50ug/100ug
U-Blot® Research Grade AdebrelimabCat. No. WA1027Request quote
Size: 50ug/100ug
U-Blot® Research Grade adargiminaseCat. No. WA1026Request quote
Size: 50ug/100ug
U-Blot® Research Grade AdalimumabCat. No. WA1025Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
FAX+(1)-866-986-9598